Related Experiment Video

Updated: Jul 17, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia

M Ikeda1, N Ozaki, T Suzuki

  • 1Department of Psychiatry, Fujita Health University School of Medicine, Aichi, Japan. ikeda-ma@fujita-hu.ac.jp

Genes, Brain, and Behavior
|January 20, 2007
PubMed

Insights

Beta-arrestin 2 (ARRB2) gene variations may be linked to methamphetamine (METH) use disorder. This genetic study found no link between ARRB2 and schizophrenia, suggesting a specific role for ARRB2 in METH pathophysiology.

Area of Science:

  • Neuroscience
  • Genetics
  • Psychiatry

Background:

  • The AKT/glycogen synthase kinase 3 (GSK3) signaling pathway is implicated in schizophrenia and methamphetamine (METH) use disorder.
  • Beta-arrestin 2 (ARRB2) is a key molecule within this signaling cascade.

Purpose of the Study:

  • To investigate the association between the ARRB2 gene and the pathophysiology of schizophrenia and METH use disorder.
  • To explore potential gene-gene interactions between ARRB2, AKT1, and GSK3B.

Main Methods:

  • A genetic case-control association analysis was performed on a Japanese population.
  • Single nucleotide polymorphisms (SNPs) in the ARRB2 gene were analyzed.
  • Gene-gene interactions were evaluated for ARRB2, AKT1, and GSK3B.

Main Results:

  • A significant association was observed between specific ARRB2 tag SNPs and METH use disorder.
  • No significant association was found between ARRB2 and schizophrenia.
  • No evidence of gene-gene interactions among ARRB2, AKT1, and GSK3B was detected in this cohort.

Conclusions:

  • The ARRB2 gene may play a role in the pathophysiology of METH use disorder.
  • ARRB2 is not significantly associated with schizophrenia in the studied population.
  • Further research is warranted to elucidate the specific mechanisms involving ARRB2 in METH use disorder.

More Related Videos

Developing a Rat Model for Bipolar Disorder04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Related Concept Videos

Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...